Qianhong Pharmaceutical
SZSE · 002550
Market Cap$7.7B
Revenue$1.5B
Employees1038
Listed OnSZSE
Ticker002550
CEO / ExecMr. Ke Wang
HeadquartersChangzhou
MarketMainland China
Websitewww.qhsh.com.cn
Overview
Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changz
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.